A Multicenter Phase II Trial of Vinorelbine Plus Gemcitabine in Previously Untreated Inoperable (Stage IIIB/IV) Non-small Cell Lung Cancer-Reference-Cited by-全球学者库

A Multicenter Phase II Trial of Vinorelbine Plus Gemcitabine in Previously Untreated Inoperable (Stage IIIB/IV) Non-small Cell Lung Cancer

Published:2000-06 Issue:6 Volume:117 Page:1583-1589
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Chen Yuh-Min,Perng Reury-Perng,Yang Kuang-Yao,Liu Tsang-Wu,Tsai Chun-Ming,Ming-Liu Jacqueline,Whang-Peng Jacqueline

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference24 articles.

1. Global cancer statistics;Parkin;CA Cancer J Clin,1999

2. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study;Abratt;J Clin Oncol,1994

3. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study;Anderson;J Clin Oncol,1994

4. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study;Perng;J Clin Oncol,1997

5. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions;Bunn;Clin Cancer Res,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine and Vinorelbine (GemVin) Regimen;Hospital Pharmacy;2014-06

2. Gemcitabine Plus Vinorelbine as an Effective Salvage Chemotherapeutic Regimen in Cisplatin-Refractory Germ Cell Tumor;Southern Medical Journal;2009-05

3. Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma;Hematology/Oncology and Stem Cell Therapy;2009-04

4. Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report;Journal of Clinical Oncology;2009-03-20

5. Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience;European Journal of Cancer Care;2008-03